key: cord-0985109-ib34awv2 authors: Raboni, SM; Giamberardino, HI; Debur, MC; Santos, JS title: ENTEROVIRUS D68-ASSOCIATED RESPIRATORY INFECTION IN SOUTHERN BRAZIL, 2018 – A POPULATION-BASED LABORATORY SURVEILLANCE date: 2020-06-11 journal: J Clin Virol DOI: 10.1016/j.jcv.2020.104503 sha: 731f90a0073a288444615f16f789e49ba0a3e17f doc_id: 985109 cord_uid: ib34awv2 Enterovirus D68 (EV-D68) strain was confirmed in 36/69 - 52.2% of enterovirus-positive samples collected through surveillance networks for severe acute respiratory infections (SARI) and influenza-like illness (ILI) in southern Brazil in 2018. This finding settles the sustained circulation of EV-D68 in southern Brazil. hospitalized at university hospital (HC/UFPR) since 2002 in Paraná (PR) state in southern Brazil, and approximately 10% cases are EV-positive (4) . Although post 2015, the public health laboratory of Paraná State (LACEN-PR) made EV detection mandatory in samples collected from hospitalized and outpatients meeting the diagnostic criteria of SARI and influenza like-illness (ILI) via active surveillance, the EV-positive samples are not routinely genotyped (4) . Here, we report the results of EV-D68 investigation in respiratory samples of SARI and ILI patients from southern Brazil. From January 2018 to December 2018, a total of 11,922 samples obtained through SARI and ILI surveillance networks were evaluated for detection of 15 respiratory viruses. The surveillance system is based on the active investigation of outpatients who develop ILI and were attended in 21 sentinel community centers distributed in 17 municipalities with the largest population of the Paraná State and all hospitalized patients with SARI in private and public institutions of the State. The case definitions for influenza surveillance are as follows: (i) ILI -an acute respiratory infection with fever of ≥ 38 °C and cough, with onset within the last 10 days; (ii) SARIpresence of ILI and other indications of disease severity, such as oxygen saturation below 95%, dyspnea, or respiratory discomfort. From each SARI and ILI cases reported to the surveillance network within 5 days of symptom onset, combined oropharyngeal and nasopharyngeal swab samples were collected and sent to the public health laboratory to be analyzed. Samples were subjected to nucleic acid extraction with QIAsymphony DSP Virus/Pathogen Kit (Qiagen, Inc., Valencia, CA), according to the manufacturer's instructions. One step qRT-PCR was performed by using the and 229E (5) (6) (7) (8) (9) . Subsequently, all respiratory (SARI and ILI) samples positive for enterovirus (EV or EV/RV) were tested for EV-D68 using a specific real-time RT-PCR technique (10) . Ct values >40.0 were considered negative. In addition, the test results were discarded for any sample whose internal control (human ribonuclease P gene) was negative. Genetic material from a positive sample was amplified using the protocol described by Nix and collaborators (11) , and molecular characterization of EV D-68 was carried out based on partial VP1 capsid gene region analysis. Nucleotide sequencing was analyzed using Enterovirus Automated Genotyping Tool (12) . Respiratory viruses were detected in 6,535 (54.8%) of SARI and ILI samples. The most frequently detected viruses were RV (15.1%), IFA (11.7%), and RSV (11.8%). Enteroviruses showed that 50% of the individuals who tested positive for EV-D68 in SARI and ILI surveillance were children, and many of them were hospitalized with SARI. In addition, we observed a high frequency of severe cases (>60%) and EV-D68 infected females. However, the disease severity of EV-D68 may have been overestimated, given that children not hospitalized owing to milder presentation were probably not sampled (14) (15) (16) (17) . Further largescale epidemiological information is needed to determine the actual burden of EV-D68. Moreover, contrary to a report from the USA (18), we observed higher frequency of EV-D68 infections in winter and summer. However, ongoing surveillance is needed to accurately define the seasonal pattern of this infection. Being closely related, PCRs for EV and RV exhibit cross-reactions leading to underestimation of EV presence. Here, EV-D68 was found only in cases previously identified as EV/RV-co-detection. Thus, our data seem to support the presence of EV-D68 and human RV cross-reactivity, as reported by McAllister and collaborators (19) . Therefore, further tests more specific for EV-D68 detection were carried out to confirm its presence. Phylogenetic studies based on the VP1 region of EV-D68 strains have shown the occurrence of clades A-D and subclades, with differences in the prevalence of the various subclades over time or in co-circulation (20) . There is no evidence that different EV lineages affect severity or clinical presentation. Acute flaccid paralysis (AFP) cases have been associated with EV-D68 detections from several lineages, including B1, B2 and B3. The B3 lineage is considered to have evolved recently, although it is not clear whether its epidemiological success is due to antigenic drift and whether its association with disease severity differs from that of other EV-D68 lineages such as B1, that was described in the 2014 outbreak (15, 21) . In 2016, during an AFP outbreak in Argentina, some children tested positive for EV-D68, lineage B3, confirming the circulation of this virus in Latin America (22) . Therefore, considering this new evidence of EV-D68 circulation in the southern Brazil region, it is highly recommended that presence of EV-D68 infection be ruled out in all AFP patients, especially where it is preceded by respiratory symptoms. This study presents the following limitations leading to EV-D68 underestimation: (a) Although most EV-D68 detections are not associated with fever, samples selected were from influenza active surveillance, which were selected based on fever presence among other SARI or ILI symptoms. (b) EV-D68 was investigated only in EV-positive samples. We found EV-D68 circulation across the Parana State in southern Brazil. Therefore, extensive population-based laboratory surveillance of EV-D68 will help evaluate the actual burden of this virus in the country and guide the implementation of effective measures to prevent future EV-D68 outbreaks. Raboni SM: Conceptualization, Methodology, Writing-Reviewing and Editing, Supervision. The Ethics Committee for Institutional Research of Hospital de Clínicas/UFPR revised and approved this study (#18714013.4.0000.0096). All procedures followed in this study were in accordance with the 1964 Helsinki Declaration and later versions. Written informed consent was obtained from patient's parents when clinical data were Enterovirus surveillance--United States Enterovirus D68: acute respiratory illness and the 2014 outbreak Low-level Circulation of Enterovirus D68-Associated Acute Respiratory Infections Impact and seasonality of human rhinovirus infection in hospitalized patients for two consecutive years Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by realtime reverse transcription-PCR assays Real-time PCR assays for detection of bocavirus in human specimens Human coronavirus infections in rural Thailand: a comprehensive study using real-time reversetranscription polymerase chain reaction assays Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens Enterovirus D68 2014 Real Time RT-PCR PCR amplification of VP1 sequences for direct identification of all from original clinical specimens MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets Enterovirus D68 detected in children with severe acute respiratory illness in Brazil Emerg Microbes Infect The emergence of Outbreak of enterovirus D68 of the new B3 lineage in Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma Seroepidemiology of enterovirus D68 infection in Surveillance for enterovirus D68 in colorado children reveals continued circulation Epidemic 2014 enterovirus D68 cross-reacts with on a human rhinovirus on a respiratory molecular diagnostic plataform Global distribution and evolutionary evolution of Enterovirus D68 Updates on the molecular epidemiology of Enterovirus D68 after installation of screening test among acute flaccid paralysis patients in Taiwan Enterovirus D68 infection in a cluster of children with acute flaccid myelitis None declared